(Q42228164)

English

Comparison of colistin-carbapenem, colistin-sulbactam, and colistin plus other antibacterial agents for the treatment of extremely drug-resistant Acinetobacter baumannii bloodstream infections.

scientific article published on 15 February 2014

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24532009%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

Comparison of colistin-carbapenem, colistin-sulbactam, and colistin plus other antibacterial agents for the treatment of extremely drug-resistant Acinetobacter baumannii bloodstream infections (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24532009%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

carbapenem antibiotic

0 references

Acinetobacter baumannii

1 reference

based on heuristic

inferred from title

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24532009%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

Fatma Aybala Altay

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24532009%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

author name string

A Batirel

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24532009%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

I I Balkan

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24532009%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

C Agalar

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24532009%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

S Akalin

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24532009%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

O Alici

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24532009%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

E Alp

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24532009%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

N Altin

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24532009%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

F Arslan

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24532009%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

T Aslan

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24532009%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

N Bekiroglu

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24532009%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

S Cesur

13

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24532009%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

A D Celik

14

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24532009%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

M Dogan

15

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24532009%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

B Durdu

16

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24532009%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

F Duygu

17

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24532009%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

A Engin

18

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24532009%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

D O Engin

19

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24532009%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

I Gonen

20

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24532009%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

E Guclu

21

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24532009%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

T Guven

22

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24532009%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

C A Hatipoglu

23

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24532009%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

S Hosoglu

24

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24532009%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

M K Karahocagil

25

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24532009%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

A U Kilic

26

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24532009%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

B Ormen

27

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24532009%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

D Ozdemir

28

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24532009%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

S Ozer

29

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24532009%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

N Oztoprak

30

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24532009%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

N Sezak

31

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24532009%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

V Turhan

32

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24532009%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

N Turker

33

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24532009%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

H Yilmaz

34

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24532009%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

publication date

15 February 2014

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24532009%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

European Journal of Clinical Microbiology & Infectious Diseases

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24532009%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

33

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24532009%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24532009%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

1311-1322

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24532009%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance

1 reference

https://api.crossref.org/works/10.1007%2FS10096-014-2070-6

21 January 2018

Therapeutic options for Acinetobacter baumannii infections

1 reference

https://api.crossref.org/works/10.1007%2FS10096-014-2070-6

21 January 2018

Acinetobacter infections: a growing threat for critically ill patients

1 reference

https://api.crossref.org/works/10.1007%2FS10096-014-2070-6

21 January 2018

Risk factors for mortality in patients with carbapenem-resistant Acinetobacter baumannii bacteremia: impact of appropriate antimicrobial therapy

1 reference

https://api.crossref.org/works/10.1007%2FS10096-014-2070-6

21 January 2018

Heteroresistance to colistin in multidrug-resistant Acinetobacter baumannii

1 reference

https://api.crossref.org/works/10.1007%2FS10096-014-2070-6

21 January 2018

Novel antibiotic combinations against infections with almost completely resistant Pseudomonas aeruginosa and Acinetobacter species

1 reference

https://api.crossref.org/works/10.1007%2FS10096-014-2070-6

21 January 2018

Combined colistin and rifampicin therapy for carbapenem-resistant Acinetobacter baumannii infections: clinical outcome and adverse events.

1 reference

https://api.crossref.org/works/10.1007%2FS10096-014-2070-6

21 January 2018

Antibiotic combinations for serious infections caused by carbapenem-resistant Acinetobacter baumannii in a mouse pneumonia model.

1 reference

https://api.crossref.org/works/10.1007%2FS10096-014-2070-6

21 January 2018

Rifampicin/imipenem combination in the treatment of carbapenem-resistant Acinetobacter baumannii infections.

1 reference

https://api.crossref.org/works/10.1007%2FS10096-014-2070-6

21 January 2018

Pharmacokinetic/pharmacodynamic assessment of the in-vivo efficacy of imipenem alone or in combination with amikacin for the treatment of experimental multiresistant Acinetobacter baumannii pneumonia

1 reference

https://api.crossref.org/works/10.1007%2FS10096-014-2070-6

21 January 2018

Evaluation of antibiotic combinations against multidrug-resistant Acinetobacter baumannii using the E-test.

1 reference

https://api.crossref.org/works/10.1007%2FS10096-014-2070-6

21 January 2018

In vitro and in vivo activity of meropenem and sulbactam against a multidrug-resistant Acinetobacter baumannii strain

1 reference

https://api.crossref.org/works/10.1007%2FS10096-014-2070-6

21 January 2018

In vitro synergy test of meropenem and sulbactam against clinical isolates of Acinetobacter baumannii.

1 reference

https://api.crossref.org/works/10.1007%2FS10096-014-2070-6

21 January 2018

Combination therapy with polymyxin B for the treatment of multidrug-resistant Gram-negative respiratory tract infections

1 reference

https://api.crossref.org/works/10.1007%2FS10096-014-2070-6

21 January 2018

Combination therapy with intravenous colistin for management of infections due to multidrug-resistant Gram-negative bacteria in patients without cystic fibrosis

1 reference

https://api.crossref.org/works/10.1007%2FS10096-014-2070-6

21 January 2018

Colistin and rifampicin in the treatment of multidrug-resistant Acinetobacter baumannii infections

1 reference

https://api.crossref.org/works/10.1007%2FS10096-014-2070-6

21 January 2018

CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting

1 reference

https://api.crossref.org/works/10.1007%2FS10096-014-2070-6

21 January 2018

Combination antibiotic therapy versus monotherapy for gram-negative bacteraemia: a commentary

1 reference

https://api.crossref.org/works/10.1007%2FS10096-014-2070-6

21 January 2018

APACHE II: a severity of disease classification system

1 reference

https://api.crossref.org/works/10.1007%2FS10096-014-2070-6

21 January 2018

Prediction of patient outcome from Acinetobacter baumannii bacteremia with Sequential Organ Failure Assessment (SOFA) and Acute Physiology and Chronic Health Evaluation (APACHE) II scores

1 reference

https://api.crossref.org/works/10.1007%2FS10096-014-2070-6

21 January 2018

A new method of classifying prognostic comorbidity in longitudinal studies: development and validation

1 reference

https://api.crossref.org/works/10.1007%2FS10096-014-2070-6

21 January 2018

Acute renal failure - definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group

1 reference

https://api.crossref.org/works/10.1007%2FS10096-014-2070-6

21 January 2018

Renal and neurological side effects of colistin in critically ill patients

1 reference

https://api.crossref.org/works/10.1007%2FS10096-014-2070-6

21 January 2018

The diversity of definitions of multidrug-resistant (MDR) and pandrug-resistant (PDR) Acinetobacter baumannii and Pseudomonas aeruginosa

1 reference

https://api.crossref.org/works/10.1007%2FS10096-014-2070-6

21 January 2018

Variability in antibiotic prescribing patterns and outcomes in patients with clinically suspected ventilator-associated pneumonia

1 reference

https://api.crossref.org/works/10.1007%2FS10096-014-2070-6

21 January 2018

In vitro activities of tigecycline combined with other antimicrobials against multiresistant gram-positive and gram-negative pathogens

1 reference

https://api.crossref.org/works/10.1007%2FS10096-014-2070-6

21 January 2018

In vitro activity of tigecycline in combination with various antimicrobials against multidrug resistant Acinetobacter baumannii.

1 reference

https://api.crossref.org/works/10.1007%2FS10096-014-2070-6

21 January 2018

Colistin therapy for microbiologically documented multidrug-resistant Gram-negative bacterial infections: a retrospective cohort study of 258 patients

1 reference

https://api.crossref.org/works/10.1007%2FS10096-014-2070-6

21 January 2018

Colistin and rifampicin compared with colistin alone for the treatment of serious infections due to extensively drug-resistant Acinetobacter baumannii: a multicenter, randomized clinical trial.

1 reference

https://api.crossref.org/works/10.1007%2FS10096-014-2070-6

21 January 2018

Is there really no benefit to combination therapy with colistin?

1 reference

https://api.crossref.org/works/10.1007%2FS10096-014-2070-6

21 January 2018

Editorial commentary: rifampicin plus colistin in the era of extensively drug-resistant Acinetobacter baumannii infections

1 reference

https://api.crossref.org/works/10.1007%2FS10096-014-2070-6

21 January 2018

Clinical and microbiological characterization of carbapenem-resistant Acinetobacter baumannii bloodstream infections.

1 reference

https://api.crossref.org/works/10.1007%2FS10096-014-2070-6

21 January 2018

Effects of Carbapenem consumption on the prevalence of Acinetobacter infection in intensive care unit patients

1 reference

https://api.crossref.org/works/10.1007%2FS10096-014-2070-6

21 January 2018

In vitro effects of sulbactam combinations with different antibiotic groups against clinical Acinetobacter baumannii isolates

1 reference

https://api.crossref.org/works/10.1007%2FS10096-014-2070-6

21 January 2018

In vitro synergistic activity of tigecycline and colistin against XDR-Acinetobacter baumannii

1 reference

https://api.crossref.org/works/10.1007%2FS10096-014-2070-6

21 January 2018

Epidemiologic, clinical characteristics, and risk factors for adverse outcome in multiresistant gram-negative primary bacteremia of critically ill patients.

1 reference

https://api.crossref.org/works/10.1007%2FS10096-014-2070-6

21 January 2018

Multidrug-resistant Acinetobacter infection mortality rate and length of hospitalization

1 reference

https://api.crossref.org/works/10.1007%2FS10096-014-2070-6

21 January 2018

Prognosis of adult patients with bacteremia caused by extensively resistant Acinetobacter baumannii

1 reference

https://api.crossref.org/works/10.1007%2FS10096-014-2070-6

21 January 2018

Evaluation of the effect of appropriate antimicrobial therapy on mortality associated with Acinetobacter nosocomialis bacteraemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/24532009

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[Evaluation of Colistin-Ampicillin/Sulbactam Combination Efficacy in Imipenem-Resistant Acinetobacter baumannii Strains]

1 reference

https://pubmed.ncbi.nlm.nih.gov/24532009

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Colistin as a salvage therapy for nosocomial infections caused by multidrug-resistant bacteria in the ICU

1 reference

https://pubmed.ncbi.nlm.nih.gov/24532009

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Colistin offers prolonged survival in experimental infection by multidrug-resistant Acinetobacter baumannii: the significance of co-administration of rifampicin

1 reference

https://pubmed.ncbi.nlm.nih.gov/24532009

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Imipenem, doxycycline and amikacin in monotherapy and in combination in Acinetobacter baumannii experimental pneumonia

1 reference

https://pubmed.ncbi.nlm.nih.gov/24532009

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Impact of early appropriate antimicrobial therapy on survival in Acinetobacter baumannii bloodstream infections

1 reference

https://pubmed.ncbi.nlm.nih.gov/24532009

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S10096-014-2070-6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24532009%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24532009%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42228164&oldid=2205144095"